Course Description
The Ask Suicide Screening Questions (ASQ) Toolkit, developed by the National Institute of Mental Health (NIMH), is a brief validated suicide risk screening tool for use among both youth and adults. Screening identifies individuals that require further mental health/suicide safety assessment. ASQ trainings assist with this management plan, aids implementation of suicide risk screening, and provides tools for the management of patients who are found to be at risk.
What You’ll Learn
Identify the crisis of youth suicide and apply the public health framework to suicide prevention in clinics and communities.
Describe how suicide prevention in the medical and school healthcare settings can be feasibly implemented through a three-tiered clinical pathway.
Describe how to utilize the Ask Suicide-Screening Questions (ASQ) tool and the ASQ Brief Suicide Safety Assessment (BSSA) as evidence-based tools that allow pediatric providers to quickly and accurately identify at-risk youth and connect them to life-saving care.
Facilitators
Lisa M. Horowitz, PhD, MPH
Dr. Lisa Horowitz is a Pediatric Psychologist and a Senior Associate Scientist at the National Institute of Mental Health at NIH. Dr. Horowitz received her doctorate in clinical psychology from George Washington University, completed a Pediatric Health Service Research Fellowship at Harvard Medical School, and obtained a Master’s in Public Health at the Harvard School of Public Health. The major focus of Dr. Horowitz’s research has been in the area of suicide prevention in the medical setting that involves validating and implementing tools for clinicians, such as the Ask Suicide-Screening Questions (ASQ). She is also one of the co-authors of the Blueprint for Youth Suicide Prevention, released by the American Academy of Pediatrics this past March. Dr. Horowitz is collaborating with hospitals, and outpatient clinics around the country, assisting with implementation of suicide risk screening and management of patients who screen positive using the ASQ Toolkit and Clinical Pathways.
